ClassID:

20265

A61K31/255 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof

Recent Application in this class:
#301
20070238782
2007-10-11

Naphthalenedione compounds for treating inflammation related disorders and microbial infection

#302
20070219268
2007-09-20

Anti-cancer activity augmentation compounds and formulations and methods of use thereof

#303
20070185186
2007-08-09

COMPOSITIONS FOR THE DELIVERY OF SUBSTITUTED NAPTHYL INDOLE DERIVATIVES AND METHODS OF THEIR USE

#304
20070155832
2007-07-05

Use of sulfonamide compounds for the treatment of diabetes and/or obesity

#305
20070135519
2007-06-14

Chemoprotective methods and compositions

#306
20070135469
2007-06-14

Vinylsulfonate and vinylsulfonamide compounds

#307
20070054839
2007-03-08

Method of inhibiting remnant lipoprotein production

#308
20070053844
2007-03-08

FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING

#309
20070043012
2007-02-22

Methods to enhance chemotherapy

#310
20070036875
2007-02-15

Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent

#311
20070025927
2007-02-01

ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES

#312
20070020384
2007-01-25

Environmentally benign crop protection agents

#313
20070020309
2007-01-25

Safe and effective biofilm inhibitory compounds and health related uses thereof

#314
20060275356
2006-12-07

Pharmaceutical compositions for treating or preventing coronary artery disease

#315
20060263439
2006-11-23

Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof

#316
20060252829
2006-11-09

Formulations and methods for treating amyloidosis

#317
20060246100
2006-11-02

Method for exfoliating skin

#318
20060234951
2006-10-19

Combination therapy for effecting weight loss and treating obesity

#319
20060223784
2006-10-05

Method and compositions for temporarily incapacitating subjects

#320
20060167095
2006-07-27

Method for treating amyloidosis

#321
20060078629
2006-04-13

Nutritional compositions and use thereof

#322
20060069039
2006-03-30

Treatment of dyskinesia

#323
20060051384
2006-03-09

Antiseptic compositions and methods of use

#324
20060020027
2006-01-26

Use of curcumanoids as histone acetyltransferases (HATs) inhibitors

#325
20060014811
2006-01-19

Medicament for treatment of cancer

#326
20060014788
2006-01-19

Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors

#327
20060009514
2006-01-12

Method for treating obesity

#328
20060009420
2006-01-12

Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate

#329
20060003950
2006-01-05

Method of treating prostatic diseases using a combination of vitamin D analogues and other agents

#330
20060003021
2006-01-05

Method of treating breast cancer using a combination of vitamin D analogues and other agents

#331
20050260250
2005-11-24

Medicinal products incorporating bound organosulfur groups

#332
20050215645
2005-09-29

Amide derivatives

#333
20050215552
2005-09-29

Method for treating obesity

#334
20050155087
2005-07-14

Method of screening compounds

#335
20050149174
2005-07-07

Medical devices to treat or inhibit restenosis

#336
20050143378
2005-06-30

Treatment of conditions through pharmacological modulation of the autonomic nervous system

#337
20050143322
2005-06-30

Method for treating obesity

#338
20050142628
2005-06-30

Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase

#339
20050137191
2005-06-23

Nitrate esters and their use for mitigating cellular damage

#340
20050137144
2005-06-23

Method for treating obesity

#341
20050124618
2005-06-09

Methods of modulating angiogenesis and cancer cell proliferation

#342
20050119330
2005-06-02

Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases

#343
20050107472
2005-05-19

Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders

#344
20050101590
2005-05-12

Antipruritics

#345
20050101543
2005-05-12

Treatments for neurogenetic disorders, impulse control disorders, and wound healing

#346
20050085547
2005-04-21

Molecules for inducing differentiation of dendritic cells

#347
20050085546
2005-04-21

Method of inducing differentiation of dendritic cells

#348
20050085537
2005-04-21

Method and composition for treating osteoporosis

#349
20050080139
2005-04-14

Naaladase inhibitors for treating huntington's disease

#350
20050080057
2005-04-14

Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity

#351
20050079502
2005-04-14

Transplant rejection suppressor

#352
20050065121
2005-03-24

Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters

#353
20050014814
2005-01-20

Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia

#354
20050014784
2005-01-20

Endostatin-like angiogenesis inhibition

#355
20050004109
2005-01-06

Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia

#356
16721688
2022-04-12

Bowel cleansing chemical composition and associated use therefore

#357
15957179
2020-03-31

Antimicrobial skin cream

#358
15614967
2019-03-26

Antimicrobial skin cream